Research Education

PerformanceLabsUK supplies independently tested research reference materials for in vitro laboratory and scientific research use only, not for human or veterinary use.

PT-141 (Bremelanotide) in Melanocortin Research Literature

Compound Research

This page summarises findings from published academic literature. It does not describe or endorse use in humans or animals, and does not imply any treatment, prevention or cure of any condition.

PT-141, also referenced in literature by its chemical name bremelanotide, is a synthetic peptide studied within melanocortin receptor pharmacology research. This page gives a general, research-framed overview of what published literature examines, for research reference purposes only.

What Is PT-141?

PT-141 is a synthetic analogue derived from a fragment of alpha-melanocyte-stimulating hormone. It is studied in research literature for its activity at melanocortin receptors, which are a family of receptors involved in a range of physiological signalling pathways studied across pharmacology research.

Areas of Published Research

Published research on PT-141 sits within melanocortin receptor pharmacology. Studies in this field typically examine receptor binding affinity and selectivity across the different melanocortin receptor subtypes, along with the cellular signalling pathways activated once the receptor is engaged. This research is conducted in laboratory and pre-clinical settings.

Melanocortin Receptor Subtypes Studied in Literature

Melanocortin receptor pharmacology research generally distinguishes between several receptor subtypes, each associated with different signalling pathways in published literature. Research on PT-141 and related compounds often specifies which subtype is being examined, since selectivity between subtypes is a central research question in this field.

Comparing Melanocortin Receptor Subtypes

Receptor subtype	General research focus in literature
MC1R	Pigmentation-related signalling pathways
MC3R	Energy homeostasis signalling research
MC4R	Central nervous system signalling pathways

Frequently asked questions

Is PT-141 approved for any medical use?

This page summarises research literature only and does not address regulatory approval status for any jurisdiction. PT-141 supplied by PerformanceLabsUK is intended strictly for in vitro laboratory research use, not for medical application in humans or animals.

Is PT-141 tested before dispatch?

Yes. Every batch is independently tested and issued with a batch-specific Certificate of Analysis before dispatch.

Is PT-141 intended for human or animal use?

No. All compounds discussed on this site are supplied strictly for in vitro laboratory research use only, and are not intended for human or animal administration.

Where can I find the Certificate of Analysis for PT-141?

Batch-specific Certificates of Analysis are published in the PerformanceLabsUK COA library, referenced against the batch number shown on the product page.

Does this page constitute medical advice?

No. This page is provided for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional for any medical concern.

Research content only. PerformanceLabsUK Ltd, company number SC883220, registered in Scotland.